16-56865272-G-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2

The NM_001126108.2(SLC12A3):​c.37G>C​(p.Ala13Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000936 in 1,613,802 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A13T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00067 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00096 ( 2 hom. )

Consequence

SLC12A3
NM_001126108.2 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:6B:2O:1

Conservation

PhyloP100: 0.512

Publications

6 publications found
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SLC12A3 Gene-Disease associations (from GenCC):
  • Gitelman syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 138 curated pathogenic missense variants (we use a threshold of 10). The gene has 18 curated benign missense variants. Gene score misZ: -0.93606 (below the threshold of 3.09). Trascript score misZ: 0.71313 (below the threshold of 3.09). GenCC associations: The gene is linked to Gitelman syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.061490893).
BP6
Variant 16-56865272-G-C is Benign according to our data. Variant chr16-56865272-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 562448.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001126108.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A3
NM_001126108.2
MANE Select
c.37G>Cp.Ala13Pro
missense
Exon 1 of 26NP_001119580.2
SLC12A3
NM_000339.3
c.37G>Cp.Ala13Pro
missense
Exon 1 of 26NP_000330.3
SLC12A3
NM_001126107.2
c.37G>Cp.Ala13Pro
missense
Exon 1 of 26NP_001119579.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A3
ENST00000563236.6
TSL:1 MANE Select
c.37G>Cp.Ala13Pro
missense
Exon 1 of 26ENSP00000456149.2
SLC12A3
ENST00000438926.6
TSL:1
c.37G>Cp.Ala13Pro
missense
Exon 1 of 26ENSP00000402152.2
SLC12A3
ENST00000566786.5
TSL:1
c.37G>Cp.Ala13Pro
missense
Exon 1 of 26ENSP00000457552.1

Frequencies

GnomAD3 genomes
AF:
0.000670
AC:
102
AN:
152214
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00110
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000651
AC:
163
AN:
250400
AF XY:
0.000701
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00113
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000963
AC:
1408
AN:
1461470
Hom.:
2
Cov.:
32
AF XY:
0.000942
AC XY:
685
AN XY:
727052
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33472
American (AMR)
AF:
0.000157
AC:
7
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000995
AC:
26
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000267
AC:
23
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53032
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5762
European-Non Finnish (NFE)
AF:
0.00115
AC:
1278
AN:
1111998
Other (OTH)
AF:
0.000944
AC:
57
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
86
172
258
344
430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000670
AC:
102
AN:
152332
Hom.:
0
Cov.:
33
AF XY:
0.000631
AC XY:
47
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000240
AC:
10
AN:
41580
American (AMR)
AF:
0.000588
AC:
9
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00110
AC:
75
AN:
68038
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000983
Hom.:
0
Bravo
AF:
0.000661
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000626
AC:
76
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00131
EpiControl
AF:
0.000889

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:6Benign:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Uncertain:4Other:1
Apr 17, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

Jul 15, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 17, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Uncertain significance and reported on 03-22-2020 by Lab or GTR ID 239772. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

not provided Pathogenic:1Uncertain:2Benign:1
Oct 05, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP2, BP4

Sep 16, 2018
Gharavi Laboratory, Columbia University
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 11, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in association with Gitelman syndrome in the published literature; however, additional clinical information and segregation information were not provided and it is unknown if a second variant was identified (PMID: 22679066); Reported along with a second variant in the SLC12A3 gene in a patient with Gitelman syndrome in the published literature; however, segregation information was not provided (PMID: 31672324); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28469853, 21415153, 34426522, 31589614, 31672324, 22679066)

Inborn genetic diseases Benign:1
Dec 30, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
0.67
DANN
Benign
0.64
DEOGEN2
Benign
0.11
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.0043
N
LIST_S2
Benign
0.52
T
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.061
T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.51
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.37
N
REVEL
Uncertain
0.51
Sift
Benign
0.40
T
Sift4G
Benign
0.82
T
Polyphen
0.0
B
Vest4
0.55
MVP
0.58
MPC
0.11
ClinPred
0.0032
T
GERP RS
1.7
PromoterAI
-0.082
Neutral
Varity_R
0.092
gMVP
0.48
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147200024; hg19: chr16-56899184; COSMIC: COSV108062381; API